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Background
Our previous studies demonstrated that natriuretic pep-
tides, i.e. BNP produced by activated satellite cells
within ischemic skeletal muscle, stimulate the regenera-
tion of neighboring endothelia via endothelial GC-A/
cGMP signaling [1]. This paracrine communication
might be critically involved in coordinating postischemic
muscle regeneration and angiogenesis. In the retina,
angiogenesis occurs as a part of normal development as
well as in proliferative vascular diseases, such as diabetic
retinopathy (DR) or retinopathy of prematurity (ROP)
[2]. Retinal vascular development is controlled by inter-
actions between ganglion cells, astrocytes and endothe-
lial cells. In particular, reciprocal feedback between
endothelial cells and astrocytes is crucial for proper vas-
cular patterning. Hypoxia-induced vascular endothelial
growth factor (VEGF) expression in astrocytes plays a
key role in (patho)physiological retinal endothelial
growth. Notably, immunohistochemistry on postnatal
(P7) retinal whole-mounts revealed the expression of
immunoreactive BNP in glial fibrillary acidic protein
(GFAP)–expressing astrocytes. Therefore we postulated
that BNP participates in this astrocyte-endothelial com-
munication during physiological vascularization and/or
pathological revascularization of the retina.
Materials and methods
We compared physiological postnatal retinal vasculariza-
tion in mice with conditional, either endothelial (EC
GC-A KO [1]) or astrocyte–restricted deletion of GC-A
(astrocyte GC-A KO) and respective control littermates
(GC-Afl/fl). The latter mouse model was generated by
crossing GC-Afl/fl mice with GFAP-CreTG mice. In addi-
tion, we studied pathological neoangiogenesis in oxygen-
induced retinopathy (OIR), a disease model for DR and
ROP [3]. These in vivo studies were complemented with
electrophysiological and molecular studies (intracellular
cGMP, VEGF secretion) in primary cultured murine
brain astrocytes.
Results
Firstly we studied whether crossing GC-Afl/fl mice with
GFAP-CreTG mice resulted in efficient and selective inacti-
vation of GC-A in astrocytes. Indeed, arterial blood pres-
sure and GC-A expression levels in peripheral tissues of
GC-Afl/fl;GFAP-Cre+/-mice were unaltered. ANP and BNP
enhanced cGMP levels in cultured control astrocytes and
these effects were significantly attenuated in astrocytes
prepared from GC-Afl/fl;GFAP-Cre+/-mice. Since these cul-
tures contained ~10% contaminating cells such as micro-
glia, we also performed single-astrocyte patch-clamp
recordings. ANP and BNP provoked membrane depolari-
zations in control astrocytes by ΔVm 1.58 ± 0.46 mV
(at 10 nM NPs) and 2.08 ± 0.51 mV (100 nM NPs).
In GC-Afl/fl;GFAP-Cre+/-astrocytes, NP-induced depolari-
zations were almost abolished: ΔVm 0.59 ± 0.35 and
0.25 ± 0.4 mV at 10 and 100 nM of the NPs.
Retinal whole-mount stainings with FITC-isolectin
demonstrated that physiological vasculogenesis 5 and
7 days after birth was unaltered both in EC GC-A KO
and astrocyte GC-A KO mice (compared with respective
control littermates). In the OIR model, pathological
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vascular regression (at P12) was also unaltered in both
genotypes. However, unexpectedly, hypoxic neovessel
formation (at P17) was unchanged in EC GC-A KO but
enhanced in astrocyte GC-A KO mice. GFAP stainings
revealed unaltered astrocyte density within and around
the neovascular zones of astrocyte GC-A KO retinas.
Hence, since astrocyte GC-A disruption apparently does
not change the vitality/proliferation of these cells but
still enhances the pathological proliferation of adjacent
endothelia, we hypothesized that NP/GC-A signaling
modulates astrocyte VEGF release.
To follow this hypothesis lastly we studied the effects
of ANP and BNP on VEGF secretion by cultured astro-
cytes. Hypoxia (1% O2 during 6 or 24h) increased VEGF
secretion by 21 fold. ANP and BNP did not significantly
modulate basal VEGF secretion but markedly and con-
centration-dependently attenuated the stimulation by
hypoxia. These inhibitory effects were almost fully abol-
ished in GC-A–deficient astrocytes.
Conclusions
Our observations indicate that BNP and/or ANP, via
GC-A/cGMP signaling, participate in a local, autocrine
or paracrine feedback which inhibits hypoxia-induced
VEGF release from retinal astrocytes and thereby mod-
erates pathological neoangiogenesis. The modulation of
VEGF-mediated communication between astrocytes and
endothelial cells by natriuretic peptides may have a key
role during processes of pathological neoangiogenesis in
the brain and retina.
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